Skip to main content

Advertisement

Log in

Polymorphic CT dinucleotide repeat in the GATA3 gene and risk of breast cancer in Iranian women

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstract

GATA3 is an enriched transcription factor in mammary epithelium. To date, there has been no study on the relationship between microsatellites in the GATA3 gene and breast cancer risk. In this study, we investigated the existence of polymorphisms in the cytosine–thymine (CT) dinucleotide repeat in intron 3 of the GATA3 gene and its association with breast cancer risk. A case–control study of 206 breast cancer patients and 262 controls was conducted in Iranian women. Several different CT repeat alleles of GATA3 were detected in both the patients and controls. The frequencies of 17 and 18 alleles in patients were significantly lower than controls. Our findings demonstrate that women who carry 17-CT (OR = 0.5; p = 0.003) or 18-CT (OR = 0.41, p = 0.02) alleles of GATA3 gene are at lower risk of developing breast cancer. The highest protection against breast cancer was observed with heterozygotes of 16/17 repeats (OR = 0.12, p = 0.02). Also, the presence of the 17-CT allele has a positive relation with estrogen receptor expression. However, we found that the allelic length of GATA3 polymorphisms had no significant effect on the age onset or grade of the disease, as well as the expression of progesterone receptors and HER2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dumitrescu RG, Cotarla I. Understanding breast cancer risk- where do we stand in 2005. J Cell Mol Med. 2005;9:208–21.

    Article  PubMed  CAS  Google Scholar 

  2. Alvarez RH. Present and future evolution of advanced breast cancer therapy. Breast Cancer Res. 2010;12(Suppl 2: S1):1–18.

    Article  Google Scholar 

  3. Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I, Najafi M, Ebrahimi M. Breast cancer in Iran: an epidemiological review. Breast J. 2007;13:383–91.

    Article  PubMed  Google Scholar 

  4. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsedeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol. 2009;20:556–63.

    Article  PubMed  CAS  Google Scholar 

  5. Yavari P, Mosavizadeh M, Sadrol-Hefazi B, Mehrabi Y. Reproductive characteristics and the risk of breast cancer—a case-control study in Iran. Asian Pac J Cancer Prev. 2005;6:370–5.

    PubMed  CAS  Google Scholar 

  6. Harirchi I, Karbakhsh M, Kashefi A, Momtahen AJ. Breast cancer in Iran: result of a multi-center study. Asian Pac J Cancer Prev. 2004;5:24.

    PubMed  Google Scholar 

  7. Zheng R, Blobel GA. GATA transcription factors and cancer. Genes Cancer. 2010;1:1178–88.

    Article  PubMed  CAS  Google Scholar 

  8. Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell. 2006;127:1041–55.

    Article  PubMed  CAS  Google Scholar 

  9. Ciocca V, Daskalakis C, Ciocca RM, Ruiz-Orrico A, Palazzo JP. The significance of GATA3 expression in breast cancer: a 10-year follow-up study. Hum Pathol. 2009;40:489–95.

    Article  PubMed  CAS  Google Scholar 

  10. Yan W, Cao QJ, Arenas RB, Bentley B, Shao R. GATA3 inhibits breast cancer metastasis through the reversal of epithelial-mesenchymal transition. J Biol Chem. 2010;285:14042–51.

    Article  PubMed  CAS  Google Scholar 

  11. Mehra R, Varambally S, Ding L, Shen R, Sabel MS, Ghosh D, Chinnaiyan AM, Kleer CG. Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis. Cancer Res. 2005;65:11259–64.

    Article  PubMed  CAS  Google Scholar 

  12. Naylor MJ, Qrmandy CJ. Gata-3 and mammary cell fate. Breast Cancer Res. 2007;2007(9):302–3.

    Article  Google Scholar 

  13. Wilson BJ, Giguere V. Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway. Mol Cancer. 2008;7:49.

    Article  PubMed  Google Scholar 

  14. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.

    Article  PubMed  CAS  Google Scholar 

  15. Bong PN, Zakaria Z, Muhammad R, Abdullah N, Ibrahim N, Emran NA, Hussain Syed NS. Expression and mutational analysis of GATA3 in Malaysian breast carcinomas. Malays J Pathol. 2010;32:117–22.

    PubMed  Google Scholar 

  16. Voduc D, Cheang M, Nielsen T. GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value. Cancer Epidemiol Biomark Prev. 2008;17:365–73.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank all patients who contributed to this investigation and Professor Farzin Farzaneh (Kings College London) and Valerie Crolley for valuable suggestions and critical reading of this manuscript. This work was supported by University of Isfahan.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tavassoli Manoochehr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zakieh, A., Simin, H., Forousan, S. et al. Polymorphic CT dinucleotide repeat in the GATA3 gene and risk of breast cancer in Iranian women. Med Oncol 30, 504 (2013). https://doi.org/10.1007/s12032-013-0504-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-013-0504-0

Keywords

Navigation